Responses
Treatment choices in cystic fibrosis and bronchiectasis: what works and when
S61 Respiratory microbiology outcomes from an observational study of ivacaftor in people with cystic fibrosis and non-G551D gating mutations (VOCAL)
Compose a Response to This Article
Other responses
No responses have been published for this article.